
Sheng Han Davis
Examiner (ID: 9566, Phone: (571)270-5823 , Office: P/1732 )
| Most Active Art Unit | 1732 |
| Art Unit(s) | 1732, 1793, 4162 |
| Total Applications | 1229 |
| Issued Applications | 726 |
| Pending Applications | 145 |
| Abandoned Applications | 383 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18064366
[patent_doc_number] => 20220395453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES
[patent_app_type] => utility
[patent_app_number] => 17/839786
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839786 | NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES | Jun 13, 2022 | Pending |
Array
(
[id] => 17895258
[patent_doc_number] => 20220304920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => Cosmetic Compositions for Skin Health and Methods of Using Same
[patent_app_type] => utility
[patent_app_number] => 17/833304
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833304
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833304 | Cosmetic Compositions for Skin Health and Methods of Using Same | Jun 5, 2022 | Pending |
Array
(
[id] => 18374369
[patent_doc_number] => 20230149448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => METHODS FOR PREVENTING AND TREATING RESPIRATORY INFECTIONS VIA MODIFICATION OF VIRUS RECEPTOR BINDING DOMAINS USING HYPOHALOUS ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/832263
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17832263
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/832263 | METHODS FOR PREVENTING AND TREATING RESPIRATORY INFECTIONS VIA MODIFICATION OF VIRUS RECEPTOR BINDING DOMAINS USING HYPOHALOUS ACIDS | Jun 2, 2022 | Pending |
Array
(
[id] => 19418590
[patent_doc_number] => 20240294713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => THERMOREVERSIBLE POLYMERS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/289733
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289733
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289733 | THERMOREVERSIBLE POLYMERS AND METHODS OF USE THEREOF | May 22, 2022 | Pending |
Array
(
[id] => 19472639
[patent_doc_number] => 12102702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Personal care compositions
[patent_app_type] => utility
[patent_app_number] => 17/743262
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12615
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743262
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743262 | Personal care compositions | May 11, 2022 | Issued |
Array
(
[id] => 18192667
[patent_doc_number] => 20230046186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => Process for the preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof
[patent_app_type] => utility
[patent_app_number] => 17/739862
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739862
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/739862 | Process for the preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof | May 8, 2022 | Abandoned |
Array
(
[id] => 17805673
[patent_doc_number] => 20220257508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
[patent_app_type] => utility
[patent_app_number] => 17/736291
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736291
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736291 | SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN | May 3, 2022 | Abandoned |
Array
(
[id] => 17988718
[patent_doc_number] => 20220354755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => SPRAYABLE COSMETIC COMPOSITION COMPRISING POLYGLYCEROL ESTERS
[patent_app_type] => utility
[patent_app_number] => 17/735667
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735667
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735667 | SPRAYABLE COSMETIC COMPOSITION COMPRISING POLYGLYCEROL ESTERS | May 2, 2022 | Abandoned |
Array
(
[id] => 20432482
[patent_doc_number] => 12502339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-23
[patent_title] => Foam compositions
[patent_app_type] => utility
[patent_app_number] => 17/734188
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 3907
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734188
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/734188 | Foam compositions | May 1, 2022 | Issued |
Array
(
[id] => 17988717
[patent_doc_number] => 20220354754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => FOAM COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/734193
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/734193 | FOAM COMPOSITIONS | May 1, 2022 | Abandoned |
Array
(
[id] => 18411992
[patent_doc_number] => 11666519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Personal care compositions with cystine
[patent_app_type] => utility
[patent_app_number] => 17/730500
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9706
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730500 | Personal care compositions with cystine | Apr 26, 2022 | Issued |
Array
(
[id] => 17790291
[patent_doc_number] => 20220249382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => COMPOSITIONS COMPRISING INDIGO AND/OR AN INDIGO DERIVATIVE AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/727510
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727510
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/727510 | COMPOSITIONS COMPRISING INDIGO AND/OR AN INDIGO DERIVATIVE AND METHODS OF USE THEREOF | Apr 21, 2022 | Abandoned |
Array
(
[id] => 17774848
[patent_doc_number] => 20220241197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
[patent_app_type] => utility
[patent_app_number] => 17/725923
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725923
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/725923 | Suspensions and diluents for metronidazole and baclofen | Apr 20, 2022 | Issued |
Array
(
[id] => 17759814
[patent_doc_number] => 20220233426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => Gel Texturizer Base for Cosmetics
[patent_app_type] => utility
[patent_app_number] => 17/719283
[patent_app_country] => US
[patent_app_date] => 2022-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719283
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/719283 | Gel texturizer base for cosmetics | Apr 11, 2022 | Issued |
Array
(
[id] => 19201362
[patent_doc_number] => 20240173261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => FORMULATION COMPRISING CERALASERTIB
[patent_app_type] => utility
[patent_app_number] => 18/552014
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552014
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552014 | FORMULATION COMPRISING CERALASERTIB | Mar 20, 2022 | Pending |
Array
(
[id] => 18869888
[patent_doc_number] => 11857668
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-01-02
[patent_title] => Underarm toner
[patent_app_type] => utility
[patent_app_number] => 17/686198
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1178
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17686198
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/686198 | Underarm toner | Mar 2, 2022 | Issued |
Array
(
[id] => 17759874
[patent_doc_number] => 20220233486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => RESPIRATORY TRACT DELIVERY OF LEVODOPA AND DOPA DECARBOXYLASE INHIBITOR FOR TREATMENT OF PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/682033
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682033
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/682033 | Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's disease | Feb 27, 2022 | Issued |
Array
(
[id] => 17836397
[patent_doc_number] => 20220273702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => HYDROGEN SULFIDE AND NITRIC OXIDE THERAPY FOR COVID-19 INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/681705
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681705
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681705 | HYDROGEN SULFIDE AND NITRIC OXIDE THERAPY FOR COVID-19 INFECTION | Feb 24, 2022 | Abandoned |
Array
(
[id] => 17609817
[patent_doc_number] => 20220152096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => IODINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/665313
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665313
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/665313 | Iodine compositions | Feb 3, 2022 | Issued |
Array
(
[id] => 20607072
[patent_doc_number] => 12582651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-24
[patent_title] => Pharmaceutical composition comprising tadalafil or pharmaceutically acceptable salt thereof and dutasteride or pharmaceutically acceptable salt thereof exhibiting novel dissolution rate
[patent_app_type] => utility
[patent_app_number] => 18/269379
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 1152
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 249
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269379
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269379 | Pharmaceutical composition comprising tadalafil or pharmaceutically acceptable salt thereof and dutasteride or pharmaceutically acceptable salt thereof exhibiting novel dissolution rate | Dec 29, 2021 | Issued |